Skip to content

Henry Schein HSIC Impairment Charges

Impairment Charges at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
$0
Baxter International logo
Baxter InternationalBAX
$0-100%
Church & Dwight logo
Church & DwightCHD
$1.7M+21.4%
Cencora logo
CencoraCOR
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Medtronic logo
MedtronicMDT

Segments

By segment

See full
Global Distribution And Value Added Services$16M+300%

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's impairment charges?
Henry Schein (HSIC) reported impairment charges of $0 in Q1 2026.
How has Henry Schein's impairment charges changed year-over-year?
Henry Schein's impairment charges decreased by 100.0% year-over-year, from $1M to $0.
What is the long-term trend for Henry Schein's impairment charges?
Over 2 years (2022 to 2024), Henry Schein's impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from $34M to $0.